These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 19725433

  • 1. Survival analysis of malignant melanoma in Japan--multivariate analysis of prognostic factors.
    Uehara S, Kamo R, Harada T, Ishii M.
    Osaka City Med J; 2009 Jun; 55(1):35-52. PubMed ID: 19725433
    [Abstract] [Full Text] [Related]

  • 2. Invasive cutaneous malignant melanoma in Sweden, 1990-1999. A prospective, population-based study of survival and prognostic factors.
    Lindholm C, Andersson R, Dufmats M, Hansson J, Ingvar C, Möller T, Sjödin H, Stierner U, Wagenius G, Swedish Melanoma Study Group.
    Cancer; 2004 Nov 01; 101(9):2067-78. PubMed ID: 15372475
    [Abstract] [Full Text] [Related]

  • 3. Independent prognostic importance of vascular invasion in nodular melanomas.
    Straume O, Akslen LA.
    Cancer; 1996 Sep 15; 78(6):1211-9. PubMed ID: 8826942
    [Abstract] [Full Text] [Related]

  • 4. Predicting five-year outcome for patients with cutaneous melanoma in a population-based study.
    Barnhill RL, Fine JA, Roush GC, Berwick M.
    Cancer; 1996 Aug 01; 78(3):427-32. PubMed ID: 8697387
    [Abstract] [Full Text] [Related]

  • 5. Prognostic factors of thin cutaneous melanoma: an analysis of the central malignant melanoma registry of the german dermatological society.
    Leiter U, Buettner PG, Eigentler TK, Garbe C.
    J Clin Oncol; 2004 Sep 15; 22(18):3660-7. PubMed ID: 15302905
    [Abstract] [Full Text] [Related]

  • 6. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients.
    Shields CL.
    Trans Am Ophthalmol Soc; 2000 Sep 15; 98():471-92. PubMed ID: 11190037
    [Abstract] [Full Text] [Related]

  • 7. N-ratio: a novel independent prognostic factor for patients with stage-III cutaneous melanoma.
    Rossi CR, Mocellin S, Pasquali S, Pilati P, Nitti D.
    Ann Surg Oncol; 2008 Jan 15; 15(1):310-5. PubMed ID: 17987346
    [Abstract] [Full Text] [Related]

  • 8. Prognostic factors in patients with thick cutaneous melanoma (> 4 mm).
    Zettersten E, Sagebiel RW, Miller JR, Tallapureddy S, Leong SP, Kashani-Sabet M.
    Cancer; 2002 Feb 15; 94(4):1049-56. PubMed ID: 11920475
    [Abstract] [Full Text] [Related]

  • 9. Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging.
    Marghoob AA, Koenig K, Bittencourt FV, Kopf AW, Bart RS.
    Cancer; 2000 Feb 01; 88(3):589-95. PubMed ID: 10649252
    [Abstract] [Full Text] [Related]

  • 10. Thick cutaneous malignant melanoma: a reappraisal of prognostic factors.
    Massi D, Borgognoni L, Franchi A, Martini L, Reali UM, Santucci M.
    Melanoma Res; 2000 Apr 01; 10(2):153-64. PubMed ID: 10803716
    [Abstract] [Full Text] [Related]

  • 11. Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma.
    Taylor RC, Patel A, Panageas KS, Busam KJ, Brady MS.
    J Clin Oncol; 2007 Mar 01; 25(7):869-75. PubMed ID: 17327608
    [Abstract] [Full Text] [Related]

  • 12. Age and gender are significant independent predictors of survival in primary cutaneous melanoma.
    Lasithiotakis K, Leiter U, Meier F, Eigentler T, Metzler G, Moehrle M, Breuninger H, Garbe C.
    Cancer; 2008 Apr 15; 112(8):1795-804. PubMed ID: 18306371
    [Abstract] [Full Text] [Related]

  • 13. Predicting ten-year survival of patients with primary cutaneous melanoma: corroboration of a prognostic model.
    Sahin S, Rao B, Kopf AW, Lee E, Rigel DS, Nossa R, Rahman IJ, Wortzel H, Marghoob AA, Bart RS.
    Cancer; 1997 Oct 15; 80(8):1426-31. PubMed ID: 9338466
    [Abstract] [Full Text] [Related]

  • 14. Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.
    Buettner PG, Leiter U, Eigentler TK, Garbe C.
    Cancer; 2005 Feb 01; 103(3):616-24. PubMed ID: 15630700
    [Abstract] [Full Text] [Related]

  • 15. Influence of biopsy on the prognosis of cutaneous melanoma of the head and neck.
    Austin JR, Byers RM, Brown WD, Wolf P.
    Head Neck; 1996 Feb 01; 18(2):107-17. PubMed ID: 8647675
    [Abstract] [Full Text] [Related]

  • 16. Improvement of overall survival of patients with cutaneous melanoma in Germany, 1976-2001: which factors contributed?
    Lasithiotakis KG, Leiter U, Eigentler T, Breuninger H, Metzler G, Meier F, Garbe C.
    Cancer; 2007 Mar 15; 109(6):1174-82. PubMed ID: 17265520
    [Abstract] [Full Text] [Related]

  • 17. Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma.
    Hoersch B, Leiter U, Garbe C.
    Br J Dermatol; 2006 Oct 15; 155(4):771-7. PubMed ID: 16965427
    [Abstract] [Full Text] [Related]

  • 18. Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an analysis of 3661 patients from a single center.
    Azzola MF, Shaw HM, Thompson JF, Soong SJ, Scolyer RA, Watson GF, Colman MH, Zhang Y.
    Cancer; 2003 Mar 15; 97(6):1488-98. PubMed ID: 12627514
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of the prognostic significance of the site of origin of cutaneous melanoma.
    Law MM, Wong JH.
    Am Surg; 1994 May 15; 60(5):362-6. PubMed ID: 8161088
    [Abstract] [Full Text] [Related]

  • 20. Prognostic variables and prognostic groups for malignant melanoma. The information from Cox and Classification And Regression Trees analysis: an Italian population-based study.
    Crocetti E, Mangone L, Lo Scocco G, Carli P.
    Melanoma Res; 2006 Oct 15; 16(5):429-33. PubMed ID: 17013092
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.